FDA Inspection
Delta Pharma, Inc.FDA Inspection 1206930 - Delta Pharma, Inc. - June 02, 2023
Record Details
This FDA Inspection record concerns Delta Pharma, Inc., with an inspection on June 2, 2023, issued by the New Orleans District Office.
- Company
- Delta Pharma, Inc.
- Inspection Date
- June 2, 2023
View Company Profile
ID · 1742a409-2a5d-4b11-aec6-e7765861703b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1206930
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Delta Pharma, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | Not classified | New Orleans District Office | Drug Quality Assurance |
| April 12, 2024 | Not classified | New Orleans District Office | Drug Quality Assurance |
| May 20, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 23, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Delta Pharma, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.